GridAI Technologies Corp. amended its CFO consulting agreement, effective September 1, 2026, setting Anna Skowron’s monthly retainer at $27,000 and granting up to 250,000 RSUs.
GRDX · GridAI Technologies Corp.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern one year from the date these financial statements are issued. ... As a result, the Company concluded that its plans at this stage do not alleviate substantial doubt about the ability to continue as a going concern.”View the 10-Q filed Aug 21, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Latest documents
GridAI Technologies Corp. advanced an additional $1,500,000 to Pronghorn Resources, LLC, evidenced by a $5,000,000 convertible note maturing on the earlier of December 31, 2026 or consummation of a Change of Control Transaction, with seven percent (7%) interest accruing from maturity.
GridAI Technologies Corp. agreed on October 22, 2026 to private placements of pre-funded and common warrants for 462,365 shares each, generating approximately $2,150,000; the warrants were issued October 26, 2026.
Manpreet Uppal resigned from GridAI Technologies Corp.’s Board of Directors and all Board committees he served on, effective October 19, 2026. His resignation was not due to any disagreement over the Company’s operations, policies or practices.
GridAI Technologies Corp. made a third loan of $536,000 to Pronghorn Resources, LLC on October 1, 2026, bringing secured convertible note principal to $3,500,000, with interest accruing after the earlier of December 31, 2026 or a change of control.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GRDX
this stock
GridAI Technologies Corp.
|
$38.65M | +16.3% | — | — | 0.4% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$137.57B | +19.7% | +46.2% | 34.9 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$98.40B | +23.2% | +20.8% | 21.0 | 2.1% |
|
MRNA
Moderna, Inc.
|
$93.61B | +684.5% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$66.55B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 30, 2026
- This year
- 28
GridAI Technologies Corp. amended its CFO consulting agreement, effective September 1, 2026, setting Anna Skowron’s monthly retainer at $27,000 and granting up to 250,000 RSUs.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GRDX | +16.1% | +21.5% | +12.0% | +9.3% | +16.3% |
| SPY | +3.3% | -1.9% | +1.5% | +0.2% | +11.0% |
| vs SPY | +12.8% | +23.4% | +10.4% | +9.1% | +5.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.